
Panrawin 40mg Injection
Marketer
Brostin Seizz Biocare
Salt Composition
Pantoprazole (40mg)
Overview Panrawin 40mg Injection
Acidomin 40mg Injection lowers stomach acid production. It treats acid-related stomach and intestinal conditions like acid reflux, peptic ulcers, and Zollinger-Ellison syndrome, relieving symptoms and promoting healing. This intravenous medication, administered by a healthcare professional, is reserved for patients where injection is deemed preferable to oral treatment by their physician. It's indicated for preventing stress ulcers in critically ill patients and pre-anesthetically to reduce aspiration risks. Acidomin 40mg Injection is a proton pump inhibitor (PPI). Dosage and treatment duration are determined by your doctor based on your condition and response. Consistent use as prescribed is crucial, even with rapid symptom improvement. Lifestyle modifications such as smaller, more frequent meals and avoidance of caffeine, spicy foods, and fatty foods can enhance treatment effectiveness. Common side effects include nausea, vomiting, headache, dizziness, gas, diarrhea, abdominal pain, and thrombophlebitis (vein inflammation). While generally mild, persistent or bothersome side effects warrant medical attention. Prolonged use, particularly over a year, may increase the risk of bone fractures, especially at higher doses. Discuss bone health strategies, including calcium and vitamin D supplementation, with your doctor. Acidomin 40mg Injection is contraindicated in patients with severe liver disease, those on HIV medications, those with a history of similar medication allergies, or existing osteoporosis. Pregnant or breastfeeding individuals should consult their doctor. Alcohol consumption should be avoided due to its acid-stimulating effect. Refrain from operating machinery or driving if dizziness or drowsiness occurs.
Primary Ingredients of Panrawin 40mg Injection
No text provided to rephrase.
Uses of Panrawin 40mg Injection
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Panrawin 40mg Injection:
Administering this medication will be handled by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Panrawin 40mg Injection:
- Diarrhea
- Flatulence
- Headache
- Joint pain
- Nausea
- Stomach pain
- Vomiting
- Dizziness
- Thrombophlebitis
How to use Panrawin 40mg Injection:
The medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Panrawin 40mg Injection works:
Gastric acid secretion is diminished by the proton pump inhibitor Panrawin 40mg Injection, providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Panrawin 40mg Injection is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of Panrawin 40mg Injection during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Consult your doctor for guidance.
Breast feedingSAFE IF PRESCRIBED
Administration of Panrawin 40mg Injection while breastfeeding appears unlikely to pose a significant health risk to the infant, based on a small amount of available human data.
DrivingCONSULT YOUR DOCTOR
Panrawin 40mg Injection's effect on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Panrawin 40mg Injection poses no safety concerns for individuals with renal impairment, and no alteration in dosage is necessary.
LiverCAUTION
For patients with severe hepatic impairment, Panrawin 40mg Injection requires careful administration. A modified dosage of Panrawin 40mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Panrawin 40mg Injection :
Omitting a scheduled dose of Panrawin 40mg Injection warrants contacting your physician.
Facts to Know About Panrawin 40mg Injection
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Active Class | Gastric acid suppressants |
